Company Filing History:
Years Active: 2025
Title: Michael McKenna: Innovator in Anti-VEGF Antibody Constructs
Introduction
Michael McKenna is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative constructs for medical applications. His work focuses on addressing critical health issues, including hearing loss.
Latest Patents
Michael McKenna holds 1 patent for his invention titled "Anti-VEGF antibody constructs." This patent provides a construct comprising a coding sequence operably linked to a promoter, wherein the coding sequence encodes a vascular endothelial growth factor (VEGF) binding agent or a portion thereof. In some embodiments, the construct is an AAV construct, which may be part of an AAV particle. The compositions comprising these constructs and AAV particles can be useful in treating hearing loss, particularly hearing loss associated with vestibular schwannoma.
Career Highlights
Michael McKenna is currently associated with Akouos, Inc., a company dedicated to developing innovative therapies for hearing loss. His expertise in biotechnology and patent development has positioned him as a key player in the industry.
Collaborations
Michael has collaborated with notable colleagues, including Emmanuel John Simons and Robert Ng, who share his commitment to advancing medical science through innovative solutions.
Conclusion
Michael McKenna's contributions to the field of biotechnology, particularly through his patent on Anti-VEGF antibody constructs, highlight his role as an influential inventor. His work continues to pave the way for advancements in treating hearing loss and improving patient outcomes.